EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic Value and Therapeutic Implications of MRI ‐Based Negative Lymph Nodes in Nasopharyngeal Carcinoma

Ze-Qi Lin, Chu-Yu He iD, Shui-Qing He iD, Dong-Yu Dai, Kai-Bin Yang iD, Ji-Bin Li, Li-Zhi Liu iD, Ying Huang, Yuan Zhang, Xu Liu, Jun Ma, Jia-Ni Liu und 1 weitere

Cancer Medicine · 2026-05 · 15 (5)

DOI: 10.1002/cam4.71953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 21.05.2026. Verfasst von Ze-Qi Lin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of …. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Nasopharyngeal Carcinoma, Lymph Nodes, Nasopharyngeal Neoplasms. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Special Support Program for Young Top Talents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the prognostic significance of negative lymph nodes (LNnegs) identified by magnetic resonance imaging (MRI) and treatment implications in patients with N0 locoregionally advanced NPC.

Methods

This retrospective cohort study included 753 patients with T3–4N0M0 NPC receiving concurrent chemoradiotherapy (CCRT) with or without induction chemotherapy (IC) at two independent hospitals. Pre‐treatment and post‐radiotherapy MRI scans were performed. Recursive partitioning analysis (RPA) stratified patients by radiological LNneg features. Cox regression and Kaplan–Meier analysis were performed with overall survival (OS) as the primary endpoint.

Results

Neck LNneg levels and the short‐axial diameter (SD) of the largest cervical LNneg were identified as significant factors associated with OS through Cox analysis (all p ≤ 0.009). Incorporating these two factors, RPA categorized patients into RPA‐I ( n = 177; ≥ 4 LNneg levels and SD decreased by > 40%) and RPA‐II ( n = 576; < 4 LNneg levels, or ≥ 4 levels and SD decreased by ≤ 40%). The 5‐year OS in RPA‐I was significantly better than in RPA‐II (98.3% vs. 89.5%; hazard ratio [HR]: 0.16; 95% confidence interval [CI]: 0.05–0.50; p < 0.001), validated after propensity score matching ( n = 177 vs. 177; HR: 0.20; 95% CI: 0.06–0.70; p = 0.005). The OS advantage of RPA‐I was significantly influenced by the cumulative cisplatin dose during CCRT (≥ 200 mg/m 2 , p < 0.001; < 200 mg/m 2 , p = 0.660), but was independent of IC (all p ≥ 0.040).

Conclusions

Dispersed LNnegs with a considerable decrease in the SD of the largest cervical LNneg in T3–4N0M0 NPC indicated a low OS risk and potential benefit from a cumulative cisplatin dose of ≥ 200 mg/m 2 in CCRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingNasopharyngeal CarcinomaLymph NodesNasopharyngeal NeoplasmsHumansFemalePrognosisRetrospective StudiesMaleChemoradiotherapyMiddle AgedLymphatic MetastasisAdultNeoplasm StagingKaplan-Meier Estimate

Stichwörter der Autor:innen

concurrent chemoradiotherapymagnetic resonance imagingnasopharyngeal carcinomanegative lymph nodeoverall survival

Autor:innen und Institutionen

  • Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial C…
  • Clinical Trials Center, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Department of Imaging Diagnosis and Interventional Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Cente…
  • Chinese Society of Clinical Oncology, Beijing, P. R. China.
  • Department of Radiation Oncology, The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, P. R. China.

ORCID-Profile: Chu-Yu He, Shui-Qing He, Kai-Bin Yang, Li-Zhi Liu, Cheng Xu

Förderung

  • National Natural Science Foundation of China
  • Guangdong Special Support Program for Young Top Talents

Zitieren

APA

Lin, Z. Q., He, C. Y., He, S. Q., Dai, D. Y., Yang, K. B., Li, J. B., Liu, L. Z., Huang, Y., Zhang, Y., Liu, X., Ma, J., Liu, J. N., & Xu, C. (2026). Prognostic Value and Therapeutic Implications of MRI ‐Based Negative Lymph Nodes in Nasopharyngeal Carcinoma. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71953

Vancouver

Lin ZQ, He CY, He SQ, Dai DY, Yang KB, Li JB, et al. Prognostic Value and Therapeutic Implications of MRI ‐Based Negative Lymph Nodes in Nasopharyngeal Carcinoma. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71953

BibTeX
@article{Lin2026,
  author = {Lin, Ze-Qi and He, Chu-Yu and He, Shui-Qing and Dai, Dong-Yu and Yang, Kai-Bin and Li, Ji-Bin and Liu, Li-Zhi and Huang, Ying and Zhang, Yuan and Liu, Xu and Ma, Jun and Liu, Jia-Ni and Xu, Cheng},
  title = {Prognostic Value and Therapeutic Implications of MRI ‐Based Negative Lymph Nodes in Nasopharyngeal Carcinoma},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/cam4.71953}
}
Kostenlos starten →